# Bisphosphonate Therapy in MONA Spectrum Disorder

> **NCT02823925** · — · COMPLETED · sponsor: **Medical University Innsbruck** · enrollment: 3 (actual)

## Conditions studied

- Bone Density
- Pain
- Fracture

## Interventions

- **DRUG:** Pamidronate or Zoledronate

## Key facts

- **NCT ID:** NCT02823925
- **Lead sponsor:** Medical University Innsbruck
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2015-01
- **Final completion:** —
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2016-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02823925

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02823925, "Bisphosphonate Therapy in MONA Spectrum Disorder". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02823925. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*